Literature DB >> 8454106

High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.

A A Motala1, M A Omar, E Gouws.   

Abstract

A four-yr prospective study was undertaken to examine the natural history of IGT in 128 South-African Indians classified as such at year 0 of the study, based on WHO criteria. Subjects were reexamined at year 1 and year 4. Of the 113 subjects who completed the study, 50.4% progressed to NIDDM (rate of progression 12.6%/yr), 24.8% persisted with IGT, and 24.8%, reverted to NGT. The majority (72%) who progressed to NIDDM did so in year 1. At year 1, 47 subjects were still classified as IGT; of the 40 subjects completing the study, 16 subjects (40%) progressed to NIDDM, 17 subjects (42.5%) persisted with IGT, and 7 subjects (17.5%) reverted to NGT. Examination of risk factors predictive of subsequent progression to NIDDM was undertaken by analysis of baseline variables in two ways: When year 0 was used as baseline (in 113 IGT0 subjects), significant predictive risk factors were the FPG and 2-h plasma glucose concentrations. All subjects who at year 0 had 2-h plasma glucose > or = 10.2 and < 11.1 mM or FPG > or = 7.3 but < 7.8 mM, subsequently progressed to NIDDM. When year 1 was used as baseline (40 IGT1 subjects), 90-min plasma glucose concentration (midtest level) was found to be a significant risk factor for development of NIDDM. In conclusion, this study has demonstrated that in South-African Indians with IGT, the majority (50.4%) progress to NIDDM within 4 yr; significant predictors of subsequent diabetes are the baseline fasting and 2-h plasma glucose concentration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454106     DOI: 10.2337/diab.42.4.556

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.

Authors:  G Nijpels; C Popp-Snijders; P J Kostense; L M Bouter; R J Heine
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

2.  Glucose metabolism among residents in Shanghai: natural outcome of a 5-year follow-up study.

Authors:  Q Qian; X Li; X Huang; M Fu; Z Meng; M Chen; B Feng
Journal:  J Endocrinol Invest       Date:  2011-07-07       Impact factor: 4.256

3.  Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study.

Authors:  Hong Wang; Nawar M Shara; Darren Calhoun; Jason G Umans; Elisa T Lee; Barbara V Howard
Journal:  Diabetes Metab Res Rev       Date:  2010-07       Impact factor: 4.876

4.  Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.

Authors:  Rosaley Prakaschandra; Datshanna Prakesh Naidoo
Journal:  Ethn Dis       Date:  2018-02-01       Impact factor: 1.847

5.  Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.

Authors:  S L Edelstein; W C Knowler; R P Bain; R Andres; E L Barrett-Connor; G K Dowse; S M Haffner; D J Pettitt; J D Sorkin; D C Muller; V R Collins; R F Hamman
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

Review 6.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 7.  A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa.

Authors:  Andre Pascal Kengne; Lucas M Ntyintyane; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2011-09-07       Impact factor: 1.167

Review 8.  Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic.

Authors:  Mandeep Bajaj; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

9.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.